Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,475,397 papers from all fields of science
Search
Sign In
Create Free Account
BYK 191023
Known as:
BYK-191023
, BYK191023
National Institutes of Health
Create Alert
Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Stimulation of brain nicotinic acetylcholine receptors activates adrenomedullary outflow via brain inducible NO synthase‐mediated S‐nitrosylation
Y. Higashi
,
Takahiro Shimizu
,
+7 authors
M. Saito
British Journal of Pharmacology
2018
Corpus ID: 51625399
We have demonstrated that i.c.v.‐administered (±)‐epibatidine, a nicotinic ACh receptor (nAChR) agonist, induced secretion of…
Expand
2010
2010
Inhibition of nitric oxide synthase during sepsis: revival because of isoform selectivity?
W. Stahl
,
M. Matějovič
,
P. Radermacher
Shock
2010
Corpus ID: 34232922
The excess release of nitric oxide (NO) resulting from the activation of the inducible isoform of the NO synthase (iNOS, NOS2) is…
Expand
2008
2008
BYK191023 (2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine) Is an NADPH- and Time-Dependent Irreversible Inhibitor of Inducible Nitric-Oxide Synthase
Mauro Tiso
,
A. Strub
,
C. Hesslinger
,
Claire T. Kenney
,
R. Boer
,
D. Stuehr
Molecular Pharmacology
2008
Corpus ID: 22119814
Imidazopyridine derivates were recently shown to be a novel class of selective and arginine-competitive inhibitors of inducible…
Expand
2008
2008
BYK 191023 ( 2-[ 2-( 4-Methoxy-pyridin-2-yl )-ethyl ]-3 H-imidazo [ 4 , 5b ] pyridine ) Is an NADPH-and Time-Dependent Irreversible Inhibitor of Inducible Nitric-Oxide Synthase
Mauro Tiso
,
A. Strub
,
C. Hesslinger
,
Claire T. Kenney
,
R. Boer
,
D. Stuehr
2008
Corpus ID: 40206049
Imidazopyridine derivates were recently shown to be a novel class of selective and arginine-competitive inhibitors of inducible…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE